1. Home
  2. VS vs ACXP Comparison

VS vs ACXP Comparison

Compare VS & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VS
  • ACXP
  • Stock Information
  • Founded
  • VS 2013
  • ACXP 2017
  • Country
  • VS Canada
  • ACXP United States
  • Employees
  • VS N/A
  • ACXP N/A
  • Industry
  • VS EDP Services
  • ACXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • VS Technology
  • ACXP Health Care
  • Exchange
  • VS Nasdaq
  • ACXP Nasdaq
  • Market Cap
  • VS 10.8M
  • ACXP 8.4M
  • IPO Year
  • VS N/A
  • ACXP 2021
  • Fundamental
  • Price
  • VS $2.02
  • ACXP $0.38
  • Analyst Decision
  • VS Hold
  • ACXP Strong Buy
  • Analyst Count
  • VS 1
  • ACXP 1
  • Target Price
  • VS $2.00
  • ACXP $12.00
  • AVG Volume (30 Days)
  • VS 23.2K
  • ACXP 107.1K
  • Earning Date
  • VS 05-19-2025
  • ACXP 05-13-2025
  • Dividend Yield
  • VS N/A
  • ACXP N/A
  • EPS Growth
  • VS N/A
  • ACXP N/A
  • EPS
  • VS N/A
  • ACXP N/A
  • Revenue
  • VS $57,288.00
  • ACXP N/A
  • Revenue This Year
  • VS $3,459.21
  • ACXP N/A
  • Revenue Next Year
  • VS N/A
  • ACXP N/A
  • P/E Ratio
  • VS N/A
  • ACXP N/A
  • Revenue Growth
  • VS N/A
  • ACXP N/A
  • 52 Week Low
  • VS $1.00
  • ACXP $0.30
  • 52 Week High
  • VS $9.59
  • ACXP $3.33
  • Technical
  • Relative Strength Index (RSI)
  • VS 48.40
  • ACXP 44.94
  • Support Level
  • VS $1.98
  • ACXP $0.34
  • Resistance Level
  • VS $2.13
  • ACXP $0.44
  • Average True Range (ATR)
  • VS 0.13
  • ACXP 0.02
  • MACD
  • VS -0.00
  • ACXP 0.00
  • Stochastic Oscillator
  • VS 31.91
  • ACXP 37.35

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Share on Social Networks: